Pharmaceutical & Life Sciences News

Grassley Wants Drug Company Execs to Testify on Drug Prices

Jan. 29, 2019, 3:16 PM

The chairman of the Senate Finance Committee issued a warning to pharmaceutical companies: Prepare to come before this panel to talk drug pricing this year.

Sen. Charles Grassley (R-Iowa) invited several drug companies to “discuss their ideas to address high drug prices” but only two agreed, he said. Some agreed to talk privately and one felt testifying publicly would “create a language barrier problem,” he said in his written opening remarks for the first hearing of the Finance Committee in this session of Congress.

Grassley said he wants more transparency from pharmaceutical companies about how they price their products and...

To read the full article log in. To learn more about a subscription click here.